DEVELOPMENT AND COMMERCIALIZATION LICENSE AGREEMENTDevelopment and Commercialization License Agreement • August 7th, 2009 • Ardea Biosciences, Inc./De • Pharmaceutical preparations • New York
This Development and Commercialization License Agreement (the “Agreement”), is entered into as of April 27, 2009 (the “Signing Date”) by and between Ardea Biosciences, Inc., a Delaware corporation, having an address of 4939 Directors Place, San Diego, California 92121, USA (“Ardea”), and Bayer Schering Pharma AG, a corporation organized under the laws of Germany, having an address of Müllerstrasse 178, 13353 Berlin, Germany (“Bayer”).
